Please login to the form below

Not currently logged in
Email:
Password:

GSK to donate 50m H1N1 vaccines

GlaxoSmithKline (GSK) has signed an agreement with the World Health Organisation (WHO) to donate 50 million doses of its adjuvanted H1N1 influenza vaccine to WHO for distribution to developing countries most in need
GlaxoSmithKline (GSK) has signed an agreement with the World Health Organisation (WHO) to donate 50 million doses of its adjuvanted H1N1 influenza vaccine to WHO for distribution to developing countries most in need.

Andrew Witty, CEO, GlaxoSmithKline said: “GSK is committed to supporting governments and health authorities around the world in their efforts to protect their populations against this pandemic. Our commitment recognises the needs of developing countries and this donation of 50 million doses will enable vaccination to begin soon in the some of the world's poorest countries.”

In addition to the donation, GSK is also supplying its vaccine to developing countries under a tiered-pricing policy based on World Bank classification and GAVI eligibility. GAVI-eligible countries, which include the world's poorest, would receive highly preferential prices based on volume orders.

Dr Margaret Chan, director-general, WHO said: “We welcome this very generous donation by GSK, which will go to protect the health of the world's poorest people. This is a real gesture of global solidarity towards those who would not otherwise be able to have access to this vaccine. WHO will now work to see that these vaccines are distributed to those who need them.”

GSK has allocated 20 per cent of overall production of its Canadian manufacturing site to developing countries. The donation to WHO is part of this allocation.

10th November 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

segmentation_pie_thumb.jpg
If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...

Infographics